Biopharma's biggest sellers – the oldies that just keep giving

Discussion in 'Pharma/Biotech Companies - In the News' started by cafead, Aug 17, 2019 at 1:52 PM.

  1. cafead

    cafead Administrator
    Staff Member

    Joined:
    Nov 21, 2001
    Messages:
    33,024
    Likes Received:
    3
    via Enbrel's recent US patent win has ensured a further eight years of exclusivity for the rheumatoid arthritis treatment. Amgen's biological had already secured its place in biopharma's hall of fame as the fourth biggest selling drug of all time to date, and currently stands to be the third biggest product looking as far ahead as 2024, according to EvaluatePharma consensus.

    article source